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Adenosine stimulation of Na± transport by an A1 receptor and a
[Ca2]-dependent mechanism. Studies were performed to determine the
primary signal transduction mechanism that mediates adenosine stimula-
tion of electrogenic sodium transport in renal epithelial cells. Experiments
were performed on cultured amphibian A6 cells with an adenosine
analogue that preferentially binds to the A1 receptor, cyclohexyladenosine(CHA). Sodium transport was assessed by the equivalent short circuit
current (Ieq). CHA was found to stimulate Ieq via activation of an A1
receptor because (1) the threshold concentration was 1 n compared to
that of 10 J.LM for the specific A2 agonist CGS21680, (2) Cl-lA inhibited
vasopressin (AVP)-stimulated cAMP production by a pertussis toxin-
sensitive mechanism, and (3) the action of CHA was inhibited by the A1
antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX). CHA increased
intracellular Ca2 ([Ca2]1) and stimulated phosphoinositide turnover at
concentrations that increased Ieq and in a time course that paralleled the
increase in Ieq. Ion transport was stimulated by a Ca2-dependent
mechanism because the CHA induced increase in Ieq was inhibited by
chelating [Ca2I with 5,S'dimethyl BAPTA in a dose-dependent manner,
with a K of approximately 10 ILM. The increase in Ieq was also dose-
dependently inhibited by the specific PKC inhibitors dihydroxychior-
promazine and cheleiythrine, and by trifluoperazine which inhibits PKC
and calmodulin. Further studies indicated that Cl-IA-stimulated Ieq was
independent of cAMP generation because Cl-IA did not induce an
increase in cAMP accummulation parallel to the increase in Ieq in a
dose-response analysis, and the adenylate cyclase inhibitor 2',5' dideoxy-
adenosine (DDA) did not affect the CHA-induced increase in Ieq. These
studies indicate, therefore, that adenosine stimulation of Ieq occurs, at
least in part, through calcium-dependent signal transduction events and
not through regulation of adenylate cyclase.
Previous studies established that hormone-stimulated electro-
genie sodium transport in renal epithelium results from an
increase in apical membrane sodium permeability due to activa-
tion or insertion of amiloride-sensitive sodium channels [reviewed
in 11. Although pioneer experiments in 1962 suggested that
stimulation of electrogenic sodium transport by vasopressin
(AVP) was attributable to the second messenger cAMP [2], recent
studies indicate that aldosterone- and insulin-stimulated electro-
genie transport are in fact mediated by a calcium-dependent
mechanism [3, 4].
The present study was performed to determine the signal
transduction system involved in adenosine activation of electro-
genie sodium transport. Adenosine is a potent paracoid and
autocoid with diverse physiological functions. While studies on its
action to regulate transepithelial ion transport have emphasized
adenosine-stimulated chloride transport [5, 6], Lang and associ-
ates have reported that adenosine also stimulates electrogenic
sodium transport in cultured A6 cells, derived from Xenopus laevis
[71. Beyond the importance of determining the cellular mecha-
nisms by which adenosine stimulates sodium transport, because
adenosine receptors are clearly located along the distal nephron
of the mammal [8], we wished to further examine the issue of
whether the electrogenic sodium transport that is activated by
multiple agonists is mediated primarily by a single common
second messenger system or, alternatively, by diverse and redun-
dant or interacting messenger systems.
Methods
Cell culture
Experiments were performed on a clone of A6 cells derived
from the kidney of Xenopus laevis. Cells were grown to confluency
on Millicell-HA cups (Millipore Corp., Bedford, MA, USA) and
were maintained in media that contained DMEM (Gibco, Grand
Island, NY, USA), glutamine (2 mM), penicillin (100 U
streptomycin (100 j.tg- ml), 10% fetal bovine serum (FBS), and
NaHCO3 (8 mM). The final composition of culture media con-
tained (mM): Na 94, Cl 94, K 4, HCO3 8, Ca 1.7, and pH of 7.6.
Since studies in this laboratory confirmed the findings of a recent
report [9] demonstrating that FBS can be removed from media
about four days after subculture without altering basal function or
hormone responsiveness, FBS was employed in culture media for
only four to six days after subculture. Experiments were per-
formed 10 to 14 days after subculture, when transmembrane
resistance was maximal. Cells were maintained at 27°C in a
humidified incubator gassed with 1% C02, and were passaged at
intervals of 7 to 10 days. Experiments were performed under
sterile conditions in a culture hood.
Cell incubations
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When test reagents were dissolved in ETOH or DMSO, the
solvents were diluted 1:100 or more since previous studies showed
an absence of cell toxicity under these conditions [31. Identical
concentrations of solvent were used in control groups. In studies
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designed to examine the effect of inhibitors of adenylate cyclase
and kinases, inhibitors were added to bathing media 10 to 20
minutes before the addition of AVP or CHA to the basal surface
of monolayers. The Ca2 chelator 5,5'diniethyl-BAPTAJAM, how-
ever, was added three hours before the stimulating agent. To some
samples, adenosine deaminase (ADA 0.5 U/mi) was added two
minutes before agonist addition to destroy all endogenously
produced adenosine. In experiments designed to inhibit the
function of G, (or G0) proteins, pertussis toxin was added to the
bathing media 18 hours before the acute experiment at a concen-
tration of 100 ng m1'. In prior studies, we found that under
these experimental conditions, such a concentration of pertussis
toxin fully ribosylated G proteins in A6 cells (unpublished data).
Sodium transport
The active surface area of cups used in transport studies was 0.6
cm2, and the potential differences across confluent monolayers
was measured with Ag/AgC12 electrodes. Current was passed with
a model DVC-1000 voltage/current clamp apparatus (WPI Indus-
tries, Sarasota, FL, USA) to estimate transepithelial resistance
(RT), which ranged from 3,000 to 6,000 [1 cm2. The short circuit
current, Isc, has been reported to equal net sodium transport in
differentiated monolayers of A6 cells [101. In the present study,
the equivalent short circuit current (Ieq) was calculated from the
open circuit measurements of VT and Rr, using Ohm's law, and
represents the net current associated with active ion flow when VT
= 0 mV. This method has theoretical advantages over the
assessment of Isc, in which a current is continuously applied to
reduce VT to zero, because ion flow across the apical membrane
is not altered due to hyperpolarization. Data are expressed as the
change in Ieq, above the initial level, observed in control and
experimental monolayers at 30 minutes after the addition of
agonist or control vehicle. Although basal Ieq varied between 1
and 5 .tA cm2 between different passages, changes induced by
agonists were proportional to basal values.
Intracellular calcium
Intracellular Ca2 ([Ca2]1) was estimated in suspended cells,
rather than in cells adherent to porous transparent membranes,
because the autofluorescence of commercially available mem-
branes prohibited adequate signal-to-noise ratios. Culture of A6
cells on non-porous surfaces was found to yield cells that did not
produce cAMP in response to AVP (positive control agonist),
suggesting that such growth conditions altered receptor expres-
sion and/or availability. In these experiments, therefore, cells were
grown on permeable Falcon membranes to permit development
of cellular polarity, and were then recovered by gentle scraping in
PBS with 5 mm EGTA (no trypsin).
Methods used to estimate {Ca2] with FURA2/AM followed
previously reported guidelines [11, 121. After resuspension in
amphibian Ringer's solution containing 8 mivi NaHCO3, 1 m
CaCI2 and 0.2% BSA, cells were exposed to FURA2/AM (10 rM)
for 60 minutes at 27°C. After washing, cells were resuspended at
approximately 1,5 X 106 cell ml1, and were incubated with
agonists and reagents as appropriate. FURA2 fluorescence was
measured in a Perkins-Elmer spectrofluorometer (Model LS-5) at
an emission of 510 nm during dual excitation at 340 and 380 nm,
Maximal and minimal fluorescence values were determined by
addition of 0.1% Triton X100 in the presence of extracellular
Ca2 or 10 mr't EGTA (pH = 8), respectively. The excitation
spectrum of the detergent-released dye matched that found after
addition of the FURA2 salt, indicating that the intracellular probe
was completely deesterifled. In intact cells, fluorescence due to
extracellular leakage of FURA2 was determined by quenching
with MnC12 (100 LM), and this value was subtracted from all
experimental values. Endogenous heavy metals were not sufficient
to interfere with [Ca2]1 determinations because pre-exposure of
cells to the heavy metal specific chelator, TPEN, did not alter
results. FURA2 was not compartmentalized intracellularly in A6
cells because there was no significant difference in fluorescence
when cells were lysed, in the presence of [Ca2]1, with either
digitonin, which preferentially permeabilizes only the plasma
membrane, or Triton X100, which permeabilizes all cellular
membranes.
Cyclic AMP measurements
Total cellular cAMP was measured with an RIA kit obtained
from Biomedical Technologies Inc. (Stoughton, MA, USA). Cells
were grown on permeable Falcon 3090 cell culture inserts with an
active surface area of 4.5 cm2. These larger membranes were used
to obtain a yield appropriate for this assay. Measurements of RT
and Ieq, basal and hormone-stimulated, confirmed that cellular
transport per unit area was similar in A6 cells grown on Milli-
pore-HA or Falcon membranes (data not shown).
The phosphodiesterase inhibitor RO-201724 (100 LM) was
added to cells to prevent breakdown of generated cAMP; this
inhibitor does not bind to adenosine receptors [13]. Cl-lA or AVP
was added 15 minutes later, and cells were incubated an addi-
tional 10 minutes. Cell reactions were terminated by addition of 1
ml cold 6% TCA and cell extracts were collected. Samples were
centrifuged at 2500 rpm to remove precipitated material, and
TCA was extracted from the cAMP supernatant by addition
of an equal volume of cold 1,1,2-trichlorotrifluoroethane/tri-N-
octylamine (8:1, vol/vol) [14]. Samples were thoroughly vortexed
to ensure adequate mixing, and the phases were then separated by
centrifugation. Control experiments with 3H-cAMP confirmed
that 100% of cAMP was recovered in the upper (neutral) aqueous
phase. Precipitated protein was resuspended by sonication in
NaOH, and sample protein concentrations were determined by
the Lowry method.
Inositol triphosphate measurement
Total cellular inositol triphosphate (1P3) was measured by high
pressure liquid chromatography [15]. Cells were seeded on Falcon
3090 cell culture inserts with an active surface area of 4.5 cm2,
grown to confluency and studied 10 to 14 days later. After
addition of myo-[3H] inositol (50 LCi/ml; Amersham), cells were
incubated (27°C) in inositol free amphibian Ringer's solution for
48 hours. There was no difference in basal or CHA-stimulated
cellular transport between cells that were maintained in Ringer's
solution for 48 hours or in culture media (data not shown). Cells
were then carefully washed three times with label-free Ringer's
solution and allowed to rest in that bathing solution for 30
minutes before addition of agonists. LiCI was not added to the
bathing solution. Reactions were stopped after exposure to the
agonist for the appropriate time by addition of 500 tI of 6% PCA,
containing phytic acid 500 j.g/mI. After further incubation for 20
minutes on ice, the supernatants were removed and neutralized
(pH 7.5) with saturated potassium bicarbonate solution. Samples
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Fig. 1. Dose-response analysis of adenosine and
adenosine analogues, and effect of a specific A1
80 antagonist, on Ieq in A6 cells. (A) Stimulation of
Ieq after a 30 mm exposure to cyclohexylad-
enosine (CHA, •), a specified A1 agonist, to
adenosine (s), and to CGS21680 (CGS, D), a
relatively selective A2 agonist. (B). The time-
course of action of CHA, reflected by the trans-
epithelial potential difference (VT). One /LM
CHA was added to the basal solution at 0 mm.
Changes in VT during the initial 5 mm are
shown by the inset. (C) Effect of amiloride (100
1LM) added to the apical solution of cells stimu-
lated with 1 /.M CHA or 100 M of CGS21680
after 2 mm. (D) Prevention of 100 nM CFIA-
induced Na transport by a highly specific A1
receptor antagonist (DPCPX). The concentra-
tions of DPCPX (in /.tM) are shown. There
were 4 to 5 culture cups in each group. Values
indicate mean SEM.
were then centrifuged (5,000 rpm) and the supernatant kept for
analyses.
Inositols were separated and identified using HPLC (Rainin
systems, Woburn, MA, USA) with a SAX hydropore column (1.4
mm x 10 cm, 1.6 ml). Loaded samples were washed and eluted at
a flow rate of 1 mi/mm, with a stepped gradient from 10 m to 25
mM NHH2PO (pFI 3.8) for 5 to 30 minutes, followed by a linear
gradient from 0.25 to 1.4 M NH4H2PO2 (pH 3.8) for 30 to 40
minutes. Radioactivity was detected using an in-line scintillation
counter (Packard Instruments, Meriden, CT, USA). The column
was calibrated using radioactive inositol standards (Amersham,
Arlington Hts, IL, USA). Preceding each new sample the column
was washed for 10 minutes with water at 1 mi/mm.
Reagents
Arginine vasopressin (AVP), adenosine deaminase (ADA;
Type V-bovine spleen), trifluoperazmne (TFP), 1,1,2-Trichiorotri-
fluoroethane and tri-N-octylamine were obtained from Sigma (St.
Louis, MO, USA). Additional chemicals were obtained from
the following vendors: cyclohexyladenosine (CHA), Boehringer-
Mannheim (Indianapolis, IN, USA); chelerythrine and forskolin
(Calbiochem, La Jolla, CA, USA); 2',5' dideoxyadenosine (DDA)
(Pharniacia, Milwaukee, WI, USA); 1,3-dipropyl-8-cyciopentylxan-
thine (DPCPX) and CGS21680, RBI, (Natick, MA, USA); pertussis
toxin, List Biologicals (Campbell, CA, USA); Ro-201724 (Biomol
Research Lab, Inc. Plymouth Meeting, PA, USA); amiloride was a
gift from Merck Sharp & Dohme Research Labs (Rahway, NJ, USA)
and 7,8-dihydroxychiorpromazine was provided by Research Bio-
chemical, Inc., as part of the Chemical Synthesis Program of the
National Institute of Mental Health, Contract 278—90-007 (BS).
Statistical analysis
Statistical comparisons were made using the unpaired Student's
t-test and a P < 0.05 denoted a statistical difference.
Results
Effect of cyclohexyladenosine (CHA) on electrogenic
sodium transport
Experiments were performed with the metabolically stable
adenosine analogue CHA, reported to have a high affinity for the
receptor that is inhibitory to adenylate cyclase (A1); the activity
constant is reported to be approximately 3 n for A1 receptors
and 30 /.LM for A2 receptors [161. As shown in Figure 1A, addition
of CHA to media bathing the basal surface of A6 monolayers
stimulated Ieq at a minimal concentration of 1 nM, consistent with
activation of A1 receptors. Higher concentrations of Cl-IA in-
creased Ieq in a progressive manner up to a fivefold increase at 1
tiM. In contrast, CG521680, an analogue of adenosine that
preferentially binds the A2 receptor, stimulated Ieq at a minimal
concentration of >1 .LM. This is also consistent with activation of
the A1 receptor, since the affinity constants of CGS21680 for the
A2 and A1 receptors are 15 nM and 1 /.LM, respectively [17]. The
threshold concentration of adenosine was found to be intermedi-
ate, between 10 and 100 flM (Fig. 1A), which corresponds to its
affinity constant for the A1 receptor of about 10 nvi [16].
Figure lB presents the time course of Cl-IA action in stimulat-
ing electrogenic sodium transport, reflected by changes in trans-
epithelial potential difference (VT). Stimulation of electrogenic
transport causes parallel changes in VT and Ieq. We elected to
measure VT rather than Ieq in this experiment because VT was
more sensitive in detection of initial changes in sodium transport
within a few seconds. This experiment was performed in a 27°C
incubator to avoid disturbances in the culture media and elec-
trodes were coupled to a paper recorder. Addition of CFIA to the
basal solution caused an immediate increase in VT within about 5
seconds. Figure 1C indicates that addition of 100 M of amiloride
to the apical solution abolished the actions of both Cl-IA and
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Fig. 2. Pertussis toxin (PTX) inhibition of the
action of CHA. (A) One hundred nM Cl-IA inhi-
bition of cAMP production induced by 1 J.M
AVP, and the abolition of this effect by PTX
(100 ng/ml). (B) PTX inhibition of CHA-stimu-
lated Ieq. The concentrations of CHA (in nM)
are shown. There were 5 culture cups in each
group. Values indicate mean SEM. These data
are representative of two separate experiments
for each type of study.
CGS21680, confirming that changes in Ieq reflected net sodium
transport.
It seemed unlikely that endogenously produced adenosine
affected either basal or CHA-stimulated Ieq. After the addition of
adenosine deaminase (ADA; 0.5 U/mi), to destroy adenosine in
the bathing media, the basal Ieq values were 1.1 0.2 xA cm2
(control) and 1.4 0.1 xA cm2 (ADA) (P = NS); 100 nM
CHA-stimulated values were 9.6 0.8 tA cm2 (control) and
8.2 1.0 pA. cm2 (ADA) (P = NS).
To confirm that the stimulatory action of CHA on electrogenic
sodium transport was mediated by an A1 receptor, additional
experiments were performed in the absence or presence of the
specific A1 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX).
In brain tissue DPCPX was found to be 500-fold more effective as an
antagonist at A1 sites than at A2 sites [181. As shown in Figure 1D,
pretreatment of monolayers with DPCPX, at concentrations of 10
LM and 100 M, completely inhibited the action of 100 nM CHA. It
seemed likely that the action of DPCPX was due to competitive
binding of the A1 receptor, since there was neither acute (30 mm)
nor chronic (24 hrs) inhibition of VT (4.0 8 mV) or RT (8205 439
fl cm) when A6 cells were exposed to DPCPX alone. The absence
of an affect of DPCPX on basal transport is consistent with the
results from the ADA experiment which failed to show biologically
significant levels of adenosine in media bathing A6 cells.
Cl-IA was also found to down-regulate adenylate cyclase via a
pertussis toxin sensitive Gi protein, as expected for an activated
A1 receptor [19]. Figure 2A demonstrates that although 1 .tM
AVP increased cAMP accumulation ninefold (P < 0.001), prein-
cubation with 100 nM Cl-IA decreased AVP-stimulated cAMP by
80%. Pretreatment with pertussis toxin, however, completely
eliminated the inhibitory effect of CHA on cAMP accumulation
[cAMP rose to 108% of the AVP-stimulated control (P = NS)].
To determine whether CHA-stimulated sodium transport was
dependent on the activation of a pertussis toxin-sensitive G
protein, the effect of this toxin on Ieq was also examined. As
shown in Figure 2B, pretreatment of cells with 100 ng/ml of the
toxin blocked the stimulatory action of CHA. This further sup-
ports a model of Cl-IA action through an A1 receptor, since such
receptors are coupled to pertussis-toxin sensitive Gi/Go proteins.
Role of intracellular calcium in the action of CHA
Because activation of an A1 receptor would not be expected to
stimulate adenylate cyclase and increase cellular cAMP, experi-
ments were performed to assess the affect of CHA on [Ca2]1
levels, using FURA2/AM. As shown in Figure 3A-C, the addition
of Cl-IA resulted in rapid and sustained increases in [Ca2]1, in a
dose-dependent manner. The time-course of action of Cl-IA-
stimulated [Ca2] paralleled the action of CHA stimulation of
Ieq (Fig. 1B). For comparison, the effect of activating nucleotide
receptors with 100 xM ATP is shown in Figure 3D. Such an
ATP-induced elevation of [Ca2}1 in A6 cells has been recently
reported [20]. It seemed unlikely that CHA stimulated Ca2
influx, because addition of 100 1M MnC12 to the bathing solution
did not result in quenching of fluorescence either before or after
addition of CHA; Mn2 enters cells via Ca2 channels and
displaces Ca2 bound to FURA2 [211.
To determine whether Cl-IA-stimulated sodium transport was
dependent on an increase in [Ca2}, monolayers were incubated
in media containing the calcium chelator 5,S'dimethyl BAPTA!
AM. Figure 4 demonstrates that preloading cells with BAPTA
inhibited the subsequent stimulation of Ieq by 100 nM Cl-IA in a
dose-dependent manner with an apparent K of approximately 10
ELM. BAPTA at 10 jxM also inhibited the effect of a lower dose of
CHA (10 nM) by approximately 50% (P < 0.01, data not shown).
As previously reported [33, preloading cells with this concentra-
tion of BAPTA did not reduce the transepithelial resistance of
monolayers below the control value of 6140 162 f cm2, or
the concentration of ionized calcium in the outside bathing
solution below the level of 1.34 m (data not shown). These
results therefore provide evidence that CHA stimulation of Ieq is
mediated by an increase in [Ca2]1.
To determine whether Cl-IA stimulated phosphoinositide turn-
over, experiments were performed to determine the time of onset
and the time of maximal increase in cellular levels of 1P3 after the
addition of CHA. As shown in Figure 5A, a significant increase in
1P3 was recorded at 20 seconds, reached a maximum at 30
seconds, and persisted for at least 120 seconds. The rapid increase
in CHA stimulation of 1P3 paralleled changes in Ieq and [Ca2]1.
An analysis of the dose dependency of 1P3 production was
performed 30 seconds after addition of CHA, in concentrations
demonstrated to stimulate Ieq. Figure SB shows that Cl-IA
increased 1P3 levels significantly at concentrations of 10 n and
above. Although 1 flM Cl-IA also increased 1P3 levels above
control, the change did not reach statistical significance. It was of
interest that, as measured at 30 seconds, 1P3 levels did not
increase progressively above the level achieved at 10 n in parallel
with changes in [Ca2]1. It seems likely that this dissociation
resulted from increased degradation of inositol triphosphates
because LiC1 was not used to block that reaction.
These studies therefore, provide strong evidence that the action
of Cl-IA to stimulate electrogenic sodium transport involves the
turnover of membrane bound phospholipids and an increase in
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Fig. 4. Effect of [Ca2] chelation by 5,S'dimethylBAPTA on Cl-IA-induced
Ieq. Dose-dependent inhibition of Ieq in cells preloaded with 5,5' dimethyl
BAPTAJAM, 1 jiM to 50 jiM. There were 4 cups in each group. Values are
mean SEM.
[Ca2] due, at least in part, to 1P3-induced release of calcium
from non-mitochondrial intracellular stores of calcium.
Role of adenylate cyclase and cAMP in the action of Cl-IA
Although Cl-IA activated the A1 receptor, the possibility re-
mained that Cl-TA may have also increased cAMP levels, due to a
finite affinity for the A2 receptor. The effect of CHA on cellular
generation of cAMP was therefore determined at concentrations
of Cl-TA which were effective in stimulating Ieq. After addition of
CHA, in concentrations of 10 nM, 100 nM and 1 jiM, the average
cAMP accumulation was significantly less than control (15 to
20%) in the presence of the phosphodiesterase inhibitor RO
201724, as shown in Figure 6A. In contrast, 1 jiM AVP stimulated
cAMP accumulation twofold above control (Fig. 6B). Experi-
ments were next performed to determine whether CHA com-
pletely blocked adenylate cyclase activation, and thus generation
of cAMP. Adenylate cyclase can be directly inhibited by 2',S'
dideoxyadenosine (DDA), which binds to the "P' site on the
catalytic subunit of this enzyme [22. The experiment shown in
Figure 6B suggests that 100 nM CHA completely blocked endog-
enous production of cAMP, because DDA did not further reduce
cAMP accumulation. The inhibitory potential of DDA was dem-
onstrated by its reduction of AVP-stimulated cAMP, to a level
comparable to that found in the presence of CHA, which was 50%
of control levels (Fig. 6B).
Further studies on other clones of the A6 cell showed that Cl-IA
could sometimes cause cAMP production to increase, to a vari-
able extent, above control. This was possibly due to indirect effects
on adenylate cyclase, or to the presence of some A2 receptors in
some clones. In each case, however, DDA inhibited the agonist-
induced rise in cAMP accumulation (data not shown). In addition,
in these experiments the possible action of endogenously pro-
duced adenosine in CHA stimulation of cAMP was evaluated.
The affect of Cl-IA on cAMP accumulation was unaltered by
addition of adenosine deaminase (ADA) compared to the action
of CHA alone (data not shown).
Despite prevention of the increased accumulation of cAMP,
however, pre-exposure to DDA did not affect CHA stimulation of
Ieq. To simplify presentation of data, experimental values are
compared to individual control groups (the absence or presence
of agonist alone) expressed as 100%. Figure 6C shows that DDA
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Fig. 5. CHA stimulation of total inositol triphos-
phate (I1'3) levels. (A) Time-dependent changes
in total cell 1P3 levels after addition of 1 .rM
Cl-IA to the basal solution. (B) Dose-dependent
stimulation of 1P3 by CHA. Data are derived
from two separate experiments, each with two
samples for each time interval or concentration.
Values are mean SEM. < 0.05.
Fig. 6. The action of CH.4 and AVP on the ac-
cumulation of cAMP. (A) Compared to control,
CHA reduced cAMP accumulation at concen-
trations that stimulated Ieq. (B) The 100 nM
CHA-induced reduction in cAMP was not de-
creased further by the adenylate cyclase inhibi-
tor 2',5'-dideoxyadenosine (DDA), although the
1 !LM AVP-stimulated increase in cAMP was
abolished. (C) DDA did not inhibit basal or
Cl-IA-stimulated Ieq. Experimental groups are
compared to individual control groups (absence
or presence of agonist alone) expressed as
100%.
neither inhibited basal Ieq nor the increase in Ieq stimulated by 10
n or 1 .LM Cl-IA. An additional experiment was performed to
determine the effect of elevated levels of cAMP on Ieq. Cells were
pretreated with RO 201724 to raise cAMP levels indirectly. Such
pretreatment did not affect the ability of 10 nM CHA to increase
Ieq (12.7 0.9 cm2 vs. 14.8 0.5 j.rA cm2 with CHA
alone), when exposed to 10 flM CHA.
Taken together, these experiments suggest that activation of
adenylate cyclase does not play a significant role in CHA stimu-
lation of Ieq.
Role of calcium dependent kinases in the action of CHA
Previous studies from this laboratory provided evidence that
aldosterone- and insulin-stimulated electrogenic sodium transport
were dependent on activation of protein kinase C (PKC) and
calmodulin kinase [3, 4]. To determine whether adenosine utilizes
similar mechanisms, the effect of specific kinase inhibitors on
CHA-stimulated Ieq was examined.
Two structurally different inhibitors of PKC were used. Dihy-
droxychlorpromazine (DHCP) is characterized by a K1 of 8.3 j.M
for PKC, compared to a K1 of 200 .LM for PKA, 65 p.M for
calmodulin-dependent PK II and 218 p.M for casein kinase [23].
As shown in Figure 7A, Cl-IA-stimulated Ieq was reduced by 50%
with 5 p.M DHCP (control, 10.2 0.9 p.A cm2 vs. experimental
5.5 0.9 p.A cm2, P < 0.001). The second inhibitor, cheleryth-
rine, a benzophenanthridine alkaloid, exhibits a K for PKC of 0.7
p.M in rat brain tissue under in vitro conditions [24]. Reported K
values for other kinases are: PKA, 0.17 mM; tyrosine protein
kinase, 0.1 mM; and [Ca2]1-dependent calmodulin kinase, >0.1
mM [24]. As shown in Figure 7B, chelerythrine reduced Cl-IA
stimulated Ieq in whole cell monolayers by about 50% at a
concentration of 7 p.M (control, 10.6 1.2 p.A cm2 vs. 5.4 0.5,
P < 0.001). Neither DHCP nor chelerythrine inhibited basal
sodium transport at the highest concentration of 10 p.M (3.0 0.4
p.A cm2, DHCP vs. 2.9 0.3, initial value and 3.5 3
p.A cm2, chelerythine vs. 3.6 0.2, initial value).
The role of calcium dependent kinases in the mediation of
CHA-stimulated Ieq was also probed with trifluoperazine (TFP)
which inhibits both calmodulin kinase [25, 261 and PKC. Figure
7C shows that TFP inhibited CHA-stimulated Ieq in a concentra-
tion dependent manner and caused nearly a 50% reduction at 20
p.M (control, 10.2 0.9 p.A cm2 vs. experimental, 5.9 0.7
p.A cm2; P < 0.001).
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Fig. 7. The dose-dependent effect of specific kinase inhibitors on CHA-
stimulated Ieq. (A) Effect of the PKC inhibitor dihydroxychiorpromazine
(DHCP). (B) Inhibitory profile of the PKC inhibitor, chelerythrine
(Chele). (C) Effect of trifluoperizine (TFP), a PKC and calmodulin kinase
inhibitor, on Ieq.
Discussion
This study was designed to determine both the receptor class
and the major signal transduction pathway utilized by adenosine
in stimulating electrogenic sodium transport in renal epithelial
cells. Because previous investigations by this laboratory demon-
strated that aldosterone, which binds to an intracellular receptor,
and insulin, which activates a cell surface receptor, each stimu-
lates sodium transport by a calcium-dependent process [3, 4], we
wished to determine whether adenosine acted through a similar
mechanism.
Figure 8, which indicates the coupling of adenosine receptors to
adenylate cyclase, provided a basis for a portion of the design of
our experiments. In this schema, two distinct receptors are linked
to adenylate cyclase (AC) by guanyl-nucleotide-binding G pro-
teins [19]. The A2 receptor, coupled to cholera toxin-sensitive G
protein, is stimulatory, while A1, coupled to a pertussis toxin-
sensitive G protein, inhibits both basal and agonist-stimulated
cAMP production. The average affinity constants for adenosine
are: A1 receptor 10 nM; A2 receptor 5 to 10 p.M; and the
intracellular P site, which is the binding site for DDA [161, 20 M.
To reduce the likelihood of activation of the A2 receptor, if
present in A6 cells, cyclohexyladenosine (CHA) was used as an
agonist because of its high selective affinity for the A1 receptor (at
least three orders of magnitude greater than that for the A2
receptor [16]).
Three sets of data support our conclusion that Cl-IA stimulation
of Ieq was mediated by an A1 receptor: (1) a minimal stimulatory
concentration of CHA at least one thousand times lower than that
of the selective A2 agonist CGS 21680; (2) a CHA-induced
inhibition of AVP-stimulated adenylate cyclase occurring via a
pertussis toxin-sensitive process; and (3) complete inhibition of
CHA-stimulated Ieq by the A1-selective antagonist DPCPX. Lang
and associates, in their initial demonstration of adenosine-stimu-
lated sodium transport, suggested that the cellular actions of
2-chloroadenosine (2-Cl-Ado) and adenosine 5'-N-ethylcarbox-
amide (NECA) were mediated by cAMP via activation of the A2
receptor [7]. There was no direct evidence to support the pro-
posed mechanism, however, because both agonists stimulated Ieq
at threshold concentrations of 10 n, while stimulation of adenyl-
ate cyclase and increased accumulation of cAMP required at least
10 LM. Since both agonists exhibit a higher affinity constant for the
A1 receptor (10 n, 2-Cl-Ado and 100 nM, NECA) than the A2
receptor (2 to 10 .tM [161), it seems likely that stimulated
electrogenic sodium transport in their study was in fact mediated
by the A1 receptor.
In the present study we investigated whether cAMP might be a
second messenger for CHA-stimulated Ieq. At concentrations of
CHA that induced an increase in Ieq, the accumulated levels of
cAMP were less than values observed in untreated cells. To
confirm this dissociation, and to address the possibility that
effector cAMP was restricted to a minor but key region of the
cytosol, A6 cells were exposed to the adenylate cyclase inhibitor
DDA at a concentration demonstrated to inhibit AVP-stimulated
hydraulic water transport [27] and dopamine inhibition of Na-K-
ATPase [281. Because DDA did not reduce cAMP accumulation
below that found after CHA administration, it seemed likely that
100 nM Cl-IA had abolished basal endogenous production of
cAMP. The potent inhibitory action of DDA on adenylate cyclase
activity was demonstrated by the abolition of AVP-stimulated
cAMP accumulation. It seems likely therefore, that DDA sup-
pressed all CHA-stimulated adenylate cyclase activity. Taken
together, these results strongly imply that CHA-stimulated Ieq is
independent of the second messenger cAMP.
In contrast, Cl-IA clearly caused an increase in [Ca2]1 levels at
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Fig. 8. Adenosine receptor coupling in A6 cells.
The relation of the adenosine receptors A2 and
A1 to adenylate cyclase (AC) and the proposed
additional pathway for CHA-stimulated Na
transport which includes PIP2 turnover and an
increase in [Ca2}. Rank orders of agonist ana-
logs for A2 and A1 receptors are indicated. Ab-
breviations are: PIP2, phosphatidylinositol 4,5-
bisphosphate; DG, diacyiglycerol; PKC; protein
kinase C; AC, adenylate cyclase; (1,4,5) 1P3,
(1,4,5) inositol triphosphate.
concentrations and with a time course that correlated with
stimulation of Ieq. The observation that increased levels of
[Ca2]1 correlated with a two- to threefold increase in 1P3 suggests
that calcium was released from intracellular non-mitochrondial
stores. Although stimulation of Ca2 influx cannot be excluded,
the absence of FURA2 quenching when MnCl2 was added to
bathing solutions suggests that calcium channels were not acti-
vated in the cell membrane [29].
The possible role of [Ca2] in stimulating Ieq was evaluated
with the intracellular Ca2 chelator 5,5'-dimethyl BAPTA. CHA-
stimulated Ieq was inhibited in BAPTA preloaded cells, with a K
of approximately 10 I.LM. Previous studies with BAPTA in the A6
cell [3] and other cells [29] have indicated that basal levels of Ca2
are not reduced at concentrations of BAPTA as high as 50 LM,
although increases in [Ca2]1 above control are markedly blunted.
These results therefore indicate that CHA stimulation of Ieq
depends on an increase in [Ca2].
In agreement with observations made in aldosterone- and
insulin-treated monolayers of A6 cells [3, 4], inhibitors of PKC and
of calmodulin kinase inhibited CHA-stimulated Ieq with apparent
K1 values near to values previously determined for isolated kinases
in vitro. While experiments with inhibitors do not prove that PKC
and calmodulin kinase mediate CHA stimulation of Ieq, they do
suggest that PKC and possibly calmodulin kinase act to up-
regulate adenosine-activated sodium transport. Further studies
involving estimates of endogenous enzyme activity and possible
agonist-induced translocation of PKC will be required to confirm
a role in the cellular action of adenosine.
Thus, in addition to the description of receptor coupling to
adenylate cyclase, Figure 8 shows a pathway also linking the A1
receptor to the hydrolysis of PIP2 and production of 1P3 and
diacyiglycerol. This schema shows that in A6 cells the pertussis
toxin-sensitive G protein that mediates CHA-stimulated Ieq may
also control down-regulation of adenylate cyclase or, alternatively,
may be independent of the adenylate cyclase system. This hypoth-
esis is consistent with and extends recent work showing that the A1
receptors can couple to a variety of effector systems independent
of adenylate cyclase, including K channels, guanylate cyclase,
phospholipase A2 and C and the Na-Ca2 exchange system
[reviewed in 30].
Of note, the CHA-induced increase in [Ca2I1 is not unique to
amphibian renal epithelial cells. Arend and associates demon-
strated the presence of both A2 and A1 receptors in primary
cultures and transfected cells derived from rabbit cortical collect-
ing duct [31, 32]. Three analogues of adenosine, NECA, CHA and
PIA (N6-R-phenylisopropyladenosine) induced an increase in
[Ca2]1 and phosphoinositide turnover, changes that were blocked
by pertussis toxin. The increase in [Ca2] was not inhibited by
reduction of external calcium, suggesting that [Ca2]1 was re-
leased from intracellular stores. As in the present study, Cl-IA
inhibited AVP-stimulated cAMP production. Similar effects of
adenosine and its analogues were demonstrated in the rabbit
medullary ascending limb of Henle's loop [33]. In the rat medul-
lary ascending limb adenosine was shown to inhibit active chloride
absorption via activation of an A1 receptor [3I.
While there are no studies yet performed that link specific
second messenger systems with ion transport in the cortical
collecting tubule, the present studies suggest that adenosine-
induced release of intracellular calcium may also lead to increased
electrogenic sodium transport in mammalian cortical collecting
duct. If this supposition is confirmed by direct measures of sodium
transport, evidence would be provided that electrogenic sodium
absorption in the distal nephron is regulated by a locally produced
agonist (adenosine), as well as by circulating hormones such as
insulin and aldosterone that produce rapid changes or slow
rhythmic changes in sodium transfer, respectively. In addition,
adenosine may act as an autocoid to augment sodium transport
initially stimulated by circulating hormones. Sodium pump turn-
over increases in parallel with sodium influx across the apical
membrane, resulting in a rise in ATP consumption and produc-
tion of adenosine. Adenosine diffuses out of the cell and may act
locally by binding to adenosine receptors to further increase apical
PIP2 —- DG —.-- PKC
AT("\, P site
cAMP
*
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membrane permeability for sodium. The potential power of such
a system includes a capacity to respond to a wide spectrum of
physiological stimuli, not limited to circulating hormones, whose
signals may converge via a shared cellular transduction mecha-
nism to elicit a single critical response.
In regard to the local production of adenosine, there is ample
evidence that local release of cellular nucleotides from nerve
endings and platelets are converted to adenosine by ecto-5'-
nucleotidase present at extracellular sites along the nephron,
including the cortical collecting tubule [reviewed in 35]. In
addition, adenosine may augment sodium transport initially stim-
ulated by circulating hormones, because the increased turnover of
the sodium pump induced by agonists that stimulate sodium
transport would be expected to increase intracellular production
and cellular efflux of adenosine.
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